Liebherr LKexv 3910 MediLine Explosion-Proof Laboratory Refrigerator

The Liebherr LKexv 3910 MediLine is a spark-free, explosion-proof laboratory refrigerator specifically engineered for the safe and compliant storage of sensitive substances, chemicals, and pharmaceutical materials. Designed according to ATEX 95 standards and EU Directive 2014/34/EU, it is essential for laboratories handling explosive and highly flammable compounds in clinical diagnostics, biotechnology, and synthetic biology research.

Key technical features include:

• Capacity: 360 litres suitable for medium-volume bioprocessing materials and molecular diagnostics reagents.
• Temperature Range: Adjustable from +3°C to +16°C with a stability that supports biomanufacturing and gene editing workflows requiring reliable cold chain storage.
• Precision Controls: Digital electronic controller with 0.1°C accuracy and calibration options ensures compliance with pharmacopoeia storage requirements.
• Explosion Protection: Certified ATEX 95 compliant for work with combustible chemicals, critical in biomedical engineering and pharmaceutical production.
• Cooling System: Forced air cooling ensures uniform temperature distribution and rapid recovery after door openings, useful in cell imaging and fluorescence analysis labs.
• Alarm System: Includes digital temperature display, memory of the last three alarms, and over/under-temperature alerts to protect valuable biological samples.
• Safety Features: Safety thermostat prevents freezing and a power failure warning light safeguards against energy loss risks.
• Construction: Durable exterior of white painted steel with an interior made of polystyrene (PS), balancing thermal insulation and ease of cleaning.
• Energy Consumption: Efficient operation at approximately 0.865 kWh/24h.

This refrigerator is widely adopted in laboratories focused on molecular biology, clinical diagnostics, and biotechnology research, providing essential temperature-controlled storage that supports regulatory compliance and sample integrity in biopharmaceutical production pipelines.